Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Cinnarizine

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT02122354Not ApplicableCompletedPrimary

Triggers and Responses to Simulator Sickness in Videogame Players

NCT01198106Not ApplicableUnknownPrimary

A Double-blind Comparison of Scopolamine With Cinnarizin for Prevention of Simulator Sickness

Showing all 2 trials

Research Network

Common Treatments

  • Cinnarizine1
  • Hide And Seek Videogame1
  • Scopolamine1

Active Sponsors

  • Medical Corps, Israel Defense Force1
  • University of Southern California1

Top Investigators

Activity Timeline